Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
25%
Ph phase_2
1
13%
Ph phase_3
1
13%
Ph not_applicable
4
50%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (12.5%)
Phase 31 (12.5%)
Phase 42 (25.0%)
N/A4 (50.0%)

Trials by Status

completed563%
recruiting113%
unknown113%
withdrawn113%

Recent Activity

1 active trials
Showing 5 of 8
completednot_applicable

Epidural Study of Patients With Chronic Lower Back Pain

NCT00887003
completednot_applicable

ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial

NCT05765266
recruitingphase_4

Depo-Medrol on Psoas After LLIF

NCT05929755
completednot_applicable

EuroPainClinics® Study II (Prospective Trial)

NCT02459392
unknownphase_3

A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults

NCT02611492
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT00887003Not Applicable

Epidural Study of Patients With Chronic Lower Back Pain

Completed
NCT05765266Not Applicable

ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial

Completed
NCT05929755Phase 4

Depo-Medrol on Psoas After LLIF

Recruiting
NCT02459392Not Applicable

EuroPainClinics® Study II (Prospective Trial)

Completed
NCT02611492Phase 3

A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults

Unknown
NCT02932020Not Applicable

AlloGen-LI Treatment of Spinal Stenosis

Withdrawn
NCT02176304Phase 4

Does Injection Site Matter? A Randomized Controlled Trial to Evaluate Efficacy of Knee Intraarticular Injections on Improval of Patient Reported Outcomes.

Completed
NCT01986465Phase 2

Effectiveness of Steroid Injection in Treating Patients With Lateral Epicondylitis

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8